Clinical Trial Update: Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

View source ↗

Summary

An exploratory, completed clinical trial evaluating the clinical response to fingolimod (Gilenya) in Hispanic patients with relapsing-remitting multiple scleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GILENYA (FINGOLIMOD HCL)

Snippet

Sponsor: University of Southern California | Conditions: Multiple Sclerosis | Status: COMPLETED